{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:06:55Z","timestamp":1722888415285},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,7,1]],"date-time":"1991-07-01T00:00:00Z","timestamp":678326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1991,7]]},"DOI":"10.1007\/bf01630723","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T14:13:38Z","timestamp":1115388818000},"page":"377-380","source":"Crossref","is-referenced-by-count":9,"title":["Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease"],"prefix":"10.1007","volume":"117","author":[{"given":"B.","family":"H\u0153rni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"Orgerie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Eghbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rojouan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zittoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Pierre-et-Marie-Curie Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-104-6-739","volume":"104","author":"G Bonadonna","year":"1986","unstructured":"Bonadonna G, Valagussa P, Santoro A (1986) Alternating noncross-resistant combination chemotherapy with ABVD or MOPP in stage IV Hodgkin's disease: a report of eight year results. Ann Intern Med 104:739\u2013746","journal-title":"Ann Intern Med"},{"key":"CR2","first-page":"5810","volume":"47","author":"VT DeVita","year":"1987","unstructured":"DeVita VT, Molloy Hubbard S, Longo DL (1987) The chemotherapy of lymphomas: looking back, moving forward. The Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 47:5810\u20135824","journal-title":"Cancer Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-8140(90)90138-M","volume":"18","author":"H Eghbali","year":"1990","unstructured":"Eghbali H, Bonichon F, David B et al. (1990) Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patients. Radiother Oncol 18:127\u2013136","journal-title":"Radiother Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.1988.6.4.679","volume":"6","author":"French Epirubicin Study Group","year":"1988","unstructured":"French Epirubicin Study Group (1988) A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin. J Clin Oncol 6:679\u2013688","journal-title":"J Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-642-83781-4_29","volume":"117","author":"B H\u0153rni","year":"1989","unstructured":"H\u0153rni B, Eghbali H (1989) Quality of life during and after treatment of Hodgkin's disease. Recent Results Cancer Res 117:257\u2013269","journal-title":"Recent Results Cancer Res"},{"key":"CR6","first-page":"789","volume":"75","author":"B H\u0153rni","year":"1988","unstructured":"H\u0153rni B, Orgerie MB, Eghbali H et al. (1988) Nouvelle association d'Epirubicine, Bl\u00e9omycine, Vinblastine et Prednisone (EBVP II) avant radioth\u00e9rapie dans les stades localis\u00e9s de maladie de Hodgkin. Essai de phase II chez 50 malades. Bull Cancer 75:789\u2013794","journal-title":"Bull Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/bjc.1989.131","volume":"59","author":"P Lagarde","year":"1989","unstructured":"Lagarde P, Bonichon F, Eghbali H, De Mascarel I, Chauvergne J, H\u0153rni B (1989) Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease. Br J Cancer 59:645\u2013649","journal-title":"Br J Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/1097-0142(19871015)60:8<1713::AID-CNCR2820600804>3.0.CO;2-C","volume":"60","author":"A Levis","year":"1987","unstructured":"Levis A, Vitolo U, Vasino MAC (1987) Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease. Cancer 60:1713\u20131719","journal-title":"Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0277-5379(87)90089-7","volume":"23","author":"HT Mouridsen","year":"1987","unstructured":"Mouridsen HT, Bastholt L, Somers R (1987) Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II\/phase III study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer Clin Oncol 23:1477\u20131483","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR10","first-page":"767","volume":"49","author":"SA Rosenberg","year":"1989","unstructured":"Rosenberg SA (1989) Hodgkin's disease: challenges for the future. Cancer Res 49:767\u2013769","journal-title":"Cancer Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1200\/JCO.1985.3.2.207","volume":"3","author":"R Zittoun","year":"1985","unstructured":"Zittoun R, Audebert A, H\u0153rni B et al. (1985) Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. J Clin Oncol 3:207\u2013214","journal-title":"J Clin Oncol"},{"key":"CR12","first-page":"151","volume":"74","author":"R Zittoun","year":"1987","unstructured":"Zittoun R, Eghbali H, Audebert A et al. (1987) Association d'\u00e9pirubicine, bl\u00e9omycine, vinblastine et prednisone (EBVP) avant radioth\u00e9rapie dans les stades localis\u00e9s de la maladie de Hodgkin. Essai de phase II. Bull Cancer 74:151\u2013157","journal-title":"Bull Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01630723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01630723\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01630723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:39:00Z","timestamp":1557254340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01630723"}},"subtitle":["Early results in 100 consecutive patients"],"short-title":[],"issued":{"date-parts":[[1991,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,7]]}},"alternative-id":["BF01630723"],"URL":"https:\/\/doi.org\/10.1007\/bf01630723","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[1991,7]]}}}